Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?-Reference-Cited by-同舟云学术

Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?

Published:2022-11-21 Issue:Supplement_4 Volume:75 Page:S530-S540
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Caskey Marina¹,Kuritzkes Daniel R²³

Affiliation:

1. Rockefeller University , New York, New York , USA

2. Division of Infectious Diseases, Brigham and Women's Hospital , Boston, Massachusetts , USA

3. Harvard Medical School , Boston, Massachusetts , USA

Abstract

Abstract Broadly neutralizing antibodies directed against human immunodeficiency virus (HIV) offer promise as long-acting agents for prevention and treatment of HIV. Progress and challenges are discussed. Lessons may be learned from the development of monoclonal antibodies to treat and prevent COVID-19.

Funder

National Institutes of Health

Harvard University

Centers for AIDS Research

BEAT-HIV

Cure

Boston HIV Clinical Trials Unit

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/article-pdf/75/Supplement_4/S530/49279010/ciac751.pdf

Reference98 articles.

1. Recent progress in broadly neutralizing antibodies to HIV;Sok;Nat Immunol,2018

2. Antibodies in HIV-1 vaccine development and therapy;Klein;Science,2013

3. Broadly neutralizing antibodies against HIV-1 and concepts for application;Gruell;Curr Opin Virol,2022

4. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection;Gray;J Virol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadly neutralizing antibodies and long-acting antiretroviral drugs as treatments for HIV;Current Opinion in HIV and AIDS;2023-05-09

2. High volume subcutaneous delivery of long-acting HIV bNAbs;The Lancet HIV;2023-04

3. Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA;Journal of Virus Eradication;2023-03

4. A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm;Clinical Infectious Diseases;2022-11-21